Article
Multiplex Base Editing to Protect from CD33-Directed Therapy: Implications for Immune and Gene Therapy
2023-02-23
Abstract excerpt
On-target toxicity to normal cells is a major safety concern with targeted immune and gene therapies. Here, we developed a base editing (BE) approach exploiting a naturally occurring CD33 single nucleotide polymorphism leading to removal of full-length CD33 surface expression on edited cells. CD33 editing in human and nonhuman primate (NHP) hematopoietic stem and progenitor cells (HSPCs) protects from CD33-targete...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f46baac0-7aa3-5e5b-8c19-a301529fefaa
- DOI
- 10.1101/2023.02.23.529353
